Literature DB >> 18927216

Inducible nitric oxide synthase is involved in endothelial dysfunction of mesenteric small arteries from hypothyroid rats.

Agostino Virdis1, Rocchina Colucci, Matteo Fornai, Antonio Polini, Elena Daghini, Emiliano Duranti, Narcisa Ghisu, Daniele Versari, Angela Dardano, Corrado Blandizzi, Stefano Taddei, Mario Del Tacca, Fabio Monzani.   

Abstract

The time-dependent effects of mild hypothyroidism on endothelial function were assessed in rat mesenteric arteries. Male Wistar rats were treated with methimazole (MMI; 0.003%) or placebo up to 16 wk. Endothelial function of mesenteric small arteries was assessed by pressurized myograph. MMI-treated animals displayed a decrease in serum thyroid hormones, an increment of plasma TSH and inflammatory cytokines, and a blunted vascular relaxation to acetylcholine, as compared with controls. Endothelial dysfunction resulted from a reduced nitric oxide (NO) availability caused by oxidative excess. Vascular-inducible NO synthase (iNOS) expression was up-regulated. S-methylisothiourea (an iNOS inhibitor) normalized endothelium-dependent relaxations and restored NO availability in arteries from 8-wk MMI-animals and partly ameliorated these alterations in 16-wk MMI rats. Similar results were obtained when MMI-induced hypothyroidism was prevented by T(4) replacement. Among controls, an impaired NO availability, secondary to oxidative excess, occurred at 16 wk, and it was less pronounced than in age-matched MMI animals. Both endothelial dysfunction and oxidant excess secondary to aging were prevented by apocynin (nicotinamide adenine dinucleotide phosphate oxidase inhibitor). Mesenteric superoxide production was reduced by S-methylisothiourea and T(4) replacement in MMI animals and abolished by apocynin in controls (dihydroethidium staining). MMI-induced mild hypothyroidism is associated with endothelial dysfunction caused by a reduced NO availability, secondary to oxidative excess. It is suggested that in this animal model, characterized by TSH elevation and low-grade inflammation, an increased expression and function of iNOS, resulting in superoxide generation, accounts for an impaired NO availability.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18927216     DOI: 10.1210/en.2008-1112

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  10 in total

1.  17β-oestradiol acts as a negative modulator of insulin-induced lactotroph cell proliferation through oestrogen receptor α, via nitric oxide/guanylyl cyclase/cGMP.

Authors:  S Gutiérrez; J P Petiti; L d V Sosa; L Fozzatti; A L De Paul; A M Masini-Repiso; A I Torres
Journal:  Cell Prolif       Date:  2010-10       Impact factor: 6.831

2.  Major adverse cardiovascular and cerebral events in hypothyroid patients undergoing percutaneous coronary intervention.

Authors:  Giuseppe Pasqualetti; Valeria Calsolaro; Fabio Monzani
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

3.  Overexpression myocardial inducible nitric oxide synthase exacerbates cardiac dysfunction and beta-adrenergic desensitization in experimental hypothyroidism.

Authors:  Qun Shao; Heng-Jie Cheng; Michael F Callahan; Dalane W Kitzman; Wei-Min Li; Che Ping Cheng
Journal:  Int J Cardiol       Date:  2015-11-06       Impact factor: 4.164

4.  American Thyroid Association Guide to investigating thyroid hormone economy and action in rodent and cell models.

Authors:  Antonio C Bianco; Grant Anderson; Douglas Forrest; Valerie Anne Galton; Balázs Gereben; Brian W Kim; Peter A Kopp; Xiao Hui Liao; Maria Jesus Obregon; Robin P Peeters; Samuel Refetoff; David S Sharlin; Warner S Simonides; Roy E Weiss; Graham R Williams
Journal:  Thyroid       Date:  2013-12-12       Impact factor: 6.568

5.  Prevention of postoperative atrial fibrillation: novel and safe strategy based on the modulation of the antioxidant system.

Authors:  Ramón Rodrigo
Journal:  Front Physiol       Date:  2012-04-12       Impact factor: 4.566

6.  Thyrotropin Regulates eNOS Expression in the Endothelium by PGRN Through Akt Pathway.

Authors:  Fengwei Jiang; Haoyu Wang; Suqing Bao; Haicheng Zhou; Yuanyuan Zhang; Yumeng Yan; Yaxin Lai; Weiping Teng; Zhongyan Shan
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-05       Impact factor: 5.555

7.  Targeted metabolomic analysis of nitric oxide/L-arginine pathway metabolites in dementia: association with pathology, severity, and structural brain changes.

Authors:  Mariusz G Fleszar; Jerzy Wiśniewski; Marzena Zboch; Dorota Diakowska; Andrzej Gamian; Małgorzata Krzystek-Korpacka
Journal:  Sci Rep       Date:  2019-09-24       Impact factor: 4.379

8.  Association between thyroid hormone parameters during early pregnancy and gestational hypertension: a prospective cohort study.

Authors:  Hua Lai; Zheng-Yu Zhan; Huai Liu
Journal:  J Int Med Res       Date:  2020-02       Impact factor: 1.671

9.  Intensification of doxorubicin-related oxidative stress in the heart by hypothyroidism is not related to the expression of cytochrome P450 NADPH-reductase and inducible nitric oxide synthase, as well as activity of xanthine oxidase.

Authors:  Jaroslaw Dudka; Franciszek Burdan; Agnieszka Korga; Magdalena Iwan; Barbara Madej-Czerwonka; Monika Cendrowska-Pinkosz; Agnieszka Korobowicz-Markiewicz; Barbara Jodlowska-Jedrych; Wlodzimierz Matysiak
Journal:  Oxid Med Cell Longev       Date:  2012-08-23       Impact factor: 6.543

10.  The effectiveness of antioxidant vitamins C and E in reducing myocardial infarct size in patients subjected to percutaneous coronary angioplasty (PREVEC Trial): study protocol for a pilot randomized double-blind controlled trial.

Authors:  Ramón Rodrigo; Daniel Hasson; Juan C Prieto; Gastón Dussaillant; Cristóbal Ramos; Lucio León; Javier Gárate; Nicolás Valls; Juan G Gormaz
Journal:  Trials       Date:  2014-05-29       Impact factor: 2.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.